WHWK
NASDAQ
$3.79
Whitehawk Therapeutics Inc (WHWK)
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. The company is headquartered in Morristown, New Jersey.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $7.50 (+97.89%)
Market Cap
$182M
EPS 5Y CAGR
+88.33%
FCF 5Y CAGR
+83.85%
Free Cash Flow Yield
-59.31%
Price Chart
Valuation
Market Cap$182M
Forward P/E2.66
P/S30.04
P/B1.62
Profitability
Gross Profit (TTM)-$99M
EBITDA-$123M
EPS-$2.46
Financial Health
Free Cash Flow Yield-59.31%
Growth & Risk
EPS 5Y CAGR+88.33%
FCF 5Y CAGR+83.85%
Beta (5Y)1.10
Sharpe Ratio1.25